China med crackdown?

Just_Mom

Well-known member
By Rob Copeland and Rebecca Robbins

Rob Copeland covers Wall Street. Rebecca Robbins covers pharmaceuticals.
Sept. 10, 2025, 5:00 a.m. ET

The Trump administration has been mulling over some pretty strict limits on meds coming from China. If they actually happen, it could mess up the whole US drug industry, from generics to new treatments.

Basically, they're thinking about an executive order that would stop any new Chinese-made experimental drugs from getting in. Big pharma's been buying up rights to these drugs for stuff like cancer, obesity, heart issues, and Crohn's.

Word of this order (which the NYT got a hold of) has got investors and companies scrambling, 'cause there's billions on the line.

Big names like Peter Thiel, Sergey Brin, the Koch family, and even folks from Jared Kushner's investment firm are pushing for a serious crackdown, saying China's a major threat to US biotech. That's according to some insiders who wanted to stay anonymous.
 
I quit worrying about peptide stuff I can't change. Instead, I'm figuring out how many freezers I can run on one circuit before I need to call an electrician to upgrade my panel.
 
Unfortunately, I think we're heading for more supply problems, slower shipping, and prices all over the place. It doesn't seem like this is aimed at our specific stuff, but I think it'll still cause issues. But the cleverness of these supply chains will adjust, and even if things change, the products will still be around.
 
Back
Top